Rep. Kennedy Signs Letter Urging Investigation into Foreign Drug Pricing Practices Shifting Costs to Americans
disproportionate share of global pharmaceutical research and development costs. In a letter to U.S. Trade Representative Jamieson Greer … pharmaceutical innovation. Many countries benefit from the U.S.-developed medicines while implementing policies that allow them to avoid